{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:28:24Z","timestamp":1794407304313,"version":"4.9.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aims to identify and explore the risk factors affecting the prognosis of pseudomyxoma peritonei patients following hyperthermic intraperitoneal chemotherapy and peritoneal cytoreductive surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      PubMed, Medline, Embase, Cochrane Library, and registers were screened. The search timeframe was set before May 2025. We calculated each potential risk factor as risk ratio (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      ) with 95%\n                      <jats:italic toggle=\"yes\">CI<\/jats:italic>\n                      . Based on sample size, Egger\u2019s\n                      <jats:italic toggle=\"yes\">P-<\/jats:italic>\n                      value, and heterogeneity, the evidence was classified as high quality (class I), moderate quality (Class II or III), and low quality (Class IV). In addition, meta regression and sensitivity analysis were performed to explore potential sources of heterogeneity and stability of results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 20 studies were included, with a total of 6612 patients. Studies with high-quality (Class I) evidence showed that pseudomyxoma peritonei patients with elevated levels of CA19-9 (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 2.30;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 1.66\u20133.20,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.00), CA125 (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 3.39;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 2.29\u20135.01,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.00) had worse prognosis. Moderate quality (Class II) evidence revealed significant associations between sex (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 1.73;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 1.25\u20132.39,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.00), CEA (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 3.16;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 1.40\u20137.12,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.01), PCI (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 1.05;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 1.01\u20131.09,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.03), CCS (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 2.10;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 1.61\u20132.76,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.00), and postoperative outcomes. Moderate quality (Class III) evidence showed that ASA classification (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 1.19;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 1.06\u20131.35,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.00) and peritoneal histopathology (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 3.82;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 2.25\u20136.49,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.00) affected the prognosis. Studies with moderate quality (Class II) evidence showed no significant association between age (\n                      <jats:italic toggle=\"yes\">RR<\/jats:italic>\n                      , 1.015;\n                      <jats:italic toggle=\"yes\">95% CI<\/jats:italic>\n                      , 0.997\u20131.033,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.05) and prognosis after CRS-HIPEC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Male, ASA classification, high-grade peritoneal histopathology and PCI are patient-related risk factors for prognosis after CRS-HIPEC, CA19-9, CA125, and CEA are tumor markers that affect prognosis. CCS is a risk factor associated with surgery. This study can guide clinicians to identify high-risk patients, implement more intensive postoperative monitoring, adjust surgical and chemotherapeutic plans, and customize long-term follow-up strategies to improve prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003107","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T17:00:13Z","timestamp":1753376413000},"page":"9622-9633","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Risk factors affecting prognosis in pseudomyxoma peritonei patients after hyperthermic intraperitoneal chemotherapy and cytoreductive surgery: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2516-4546","authenticated-orcid":false,"given":"Xueyi","family":"Wei","sequence":"first","affiliation":[{"name":"Xiangya School of Nursing, Central South University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liao","sequence":"additional","affiliation":[{"name":"Teaching and Research Section of Clinical Nursing, Xiangya Hospital, Central South University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-4232","authenticated-orcid":false,"given":"Xiuwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Xiangya School of Nursing, Central South University, China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"11\u201335","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-021-01723-6","article-title":"Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines","volume":"16","author":"Lin","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R3-20261030","doi-asserted-by":"crossref","first-page":"511\u201319","DOI":"10.1080\/02656736.2017.1310938","article-title":"Pseudomyxoma peritonei: natural history and treatment","volume":"33","author":"Mittal","year":"2017","journal-title":"Int J Hyperthermia"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"2226\u201332","DOI":"10.1016\/j.ejso.2022.06.013","article-title":"Prevalence and incidence of pseudomyxoma peritonei in urban china: a nationwide retrospective cohort study","volume":"48","author":"Feng","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"49\u201356","DOI":"10.4240\/wjgs.v10.i5.49","article-title":"Approach to pseudomyxoma peritonei","volume":"10","author":"Rizvi","year":"2018","journal-title":"World J Gastrointest Surg"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"252\u201357","DOI":"10.1245\/s10434-020-08655-8","article-title":"Estimating the prevalence of pseudomyxoma peritonei in europe using a novel statistical method","volume":"28","author":"Patrick-Brown","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"76\u201382","DOI":"10.1245\/s10434-017-6214-7","article-title":"Impact of cellularity on oncologic outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for pseudomyxoma peritonei","volume":"25","author":"Choudry","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R8-20261030","doi-asserted-by":"crossref","first-page":"2182749","DOI":"10.1080\/02656736.2023.2182749","article-title":"Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control study","volume":"40","author":"Yang","year":"2023","journal-title":"Int J Hyperthermia"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"1323796","DOI":"10.3389\/fonc.2024.1323796","article-title":"Global trends in research of pseudomyxoma peritonei: a bibliometric and visualization analysis","volume":"14","author":"Liu","year":"2024","journal-title":"Front Oncol"},{"key":"R10-20261030","doi-asserted-by":"crossref","first-page":"818\u201325","DOI":"10.21037\/gs-22-170","article-title":"Enteral nutrition provides favorable postoperative outcomes for patients with pseudomyxoma peritonei: a retrospective study","volume":"11","author":"Kuang","year":"2022","journal-title":"Gland Surg"},{"key":"R11-20261030","doi-asserted-by":"crossref","first-page":"256\u201366","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Quenet","year":"2021","journal-title":"Lancet Oncol"},{"key":"R12-20261030","doi-asserted-by":"crossref","first-page":"334\u201342","DOI":"10.1002\/cam4.80","article-title":"A contemporary analysis of morbidity and outcomes in cytoreduction\/hyperthermic intraperitoneal chemoperfusion","volume":"2","author":"Haslinger","year":"2013","journal-title":"Cancer Med"},{"key":"R13-20261030","first-page":"163\u201367","article-title":"Systemic inflammatory markers for the detection of infectious complications and safe discharge after cytoreductive surgery and HIPEC","volume":"34","author":"Viyuela","year":"2020","journal-title":"Surg Oncol"},{"key":"R14-20261030","first-page":"2745\u201352","article-title":"Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy","volume":"28","author":"Smibert","year":"2020","journal-title":"Support Care Cancer"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00384-024-04741-5","article-title":"Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta-analysis and systematic review","volume":"39","author":"Chen","year":"2024","journal-title":"Int J Colorectal Dis"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"2656\u201362","DOI":"10.1245\/s10434-014-4297-y","article-title":"Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis","volume":"22","author":"Simkens","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"1605\u201313","DOI":"10.1016\/j.ejso.2014.08.477","article-title":"Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review","volume":"40","author":"Seretis","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R18-20261030","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R19-20261030","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Bmj"},{"key":"R20-20261030","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"603\u201305","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"153\u201364","DOI":"10.1016\/j.ijsu.2019.08.003","article-title":"Risk factors for recurrence after anal fistula surgery: a meta-analysis","volume":"69","author":"Mei","year":"2019","journal-title":"Int J Surg"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"455\u201363","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"629\u201334","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"2372356","DOI":"10.1080\/02656736.2024.2372356","article-title":"Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified?","volume":"41","author":"Enblad","year":"2024","journal-title":"Int J Hyperthermia"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"701\u201310","DOI":"10.1002\/ags3.12791","article-title":"Long-term outcomes and survival analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei at a newly established peritoneal malignancy centre in japan","volume":"8","author":"Yano","year":"2024","journal-title":"Ann Gastroenterol Surg"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/jmas.jmas_299_23","article-title":"Analysis of risk factors for major post-operative complications following intraperitoneal hyperthermic perfusion for pseudomyxoma peritonei: a retrospective cohort study","volume":"21","author":"Zhang","year":"2025","journal-title":"J Minim Access Surg"},{"key":"R28-20261030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12957-024-03412-7","article-title":"Analysis of causes and prognostic impact of tube occlusion during hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei","volume":"22","author":"Liu","year":"2024","journal-title":"World J Surg Oncol"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/cancers15041326","article-title":"Prognostic factors in pseudomyxoma peritonei with emphasis on the predictive role of peritoneal cancer index and tumor markers","volume":"15","author":"Blaj","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12957-023-03232-1","article-title":"Long-term survival in patients with PMP: a single-institutional retrospective study from china","volume":"21","author":"Yang","year":"2023","journal-title":"World J Surg Oncol"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-023-11404-1","article-title":"Etiological analysis of infection after CRS\u2009+\u2009HIPEC in patients with PMP","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"522\u201330","DOI":"10.1001\/jamasurg.2023.0112","article-title":"Development and validation of nomograms to predict survival in patients undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin","volume":"158","author":"Chandrakumaran","year":"2023","journal-title":"JAMA Surg"},{"key":"R33-20261030","doi-asserted-by":"crossref","first-page":"967296","DOI":"10.3389\/fsurg.2022.967296","article-title":"Prognostic value of the ascites characteristics in pseudomyxoma peritonei originating from the appendix","volume":"9","author":"Wang","year":"2023","journal-title":"Front Surg"},{"key":"R34-20261030","first-page":"2637\u201345","article-title":"Survival prediction by bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy","volume":"12","author":"Zhao","year":"2023","journal-title":"Cancer Med"},{"key":"R35-20261030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13000-021-01177-1","article-title":"Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study","volume":"16","author":"Ma","year":"2021","journal-title":"Diagn Pathol"},{"key":"R36-20261030","doi-asserted-by":"crossref","first-page":"1459\u201367","DOI":"10.1002\/jso.26671","article-title":"Nomogram to predict overall survival of patients with pseudomyxoma peritonei of appendiceal origin: a retrospective cohort study","volume":"124","author":"Bai","year":"2021","journal-title":"J Surg Oncol"},{"key":"R37-20261030","doi-asserted-by":"crossref","first-page":"899\u2013906","DOI":"10.1007\/s11605-019-04239-4","article-title":"Outcomes following cytoreduction and HIPEC for pseudomyxoma peritonei: 10-year experience","volume":"24","author":"Narasimhan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"R38-20261030","doi-asserted-by":"crossref","first-page":"600\u201306","DOI":"10.1016\/j.ejso.2020.01.017","article-title":"Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: experience on 254 patients from a single center","volume":"46","author":"Li","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"R39-20261030","doi-asserted-by":"crossref","first-page":"376\u201386","DOI":"10.1002\/bjs5.50134","article-title":"Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms","volume":"3","author":"van Eden","year":"2019","journal-title":"BJS Open"},{"key":"R40-20261030","first-page":"1429\u201336","article-title":"Pleuropulmonary recurrence following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for appendiceal pseudomyxoma peritonei","volume":"26","author":"Beane","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R41-20261030","doi-asserted-by":"crossref","first-page":"4222\u201330","DOI":"10.1245\/s10434-016-5350-9","article-title":"Pseudomyxoma peritonei of extra-appendiceal origin: a comparative study","volume":"23","author":"Baratti","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R42-20261030","doi-asserted-by":"crossref","first-page":"1035\u201341","DOI":"10.1016\/j.ejso.2016.03.017","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours","volume":"42","author":"Ansari","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R43-20261030","doi-asserted-by":"crossref","first-page":"3963\u201369","DOI":"10.1245\/s10434-014-3807-2","article-title":"Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms?","volume":"21","author":"Polanco","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R44-20261030","doi-asserted-by":"crossref","first-page":"911\u201319","DOI":"10.1016\/j.ejso.2015.03.231","article-title":"Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis","volume":"41","author":"Coccolini","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"R45-20261030","doi-asserted-by":"crossref","first-page":"383\u201388","DOI":"10.1016\/j.ejso.2018.10.545","article-title":"Short-term complications in elderly patients undergoing CRS and HIPEC: a single center\u2019s initial experience","volume":"45","author":"Oemrawsingh","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R46-20261030","doi-asserted-by":"crossref","first-page":"709\u201319","DOI":"10.1245\/s10434-017-6313-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the elderly: is it reasonable? A meta-analysis","volume":"25","author":"Gagniere","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R47-20261030","doi-asserted-by":"crossref","first-page":"693\u201398","DOI":"10.1007\/s00423-015-1325-8","article-title":"Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPEC","volume":"400","author":"Beckert","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"R48-20261030","doi-asserted-by":"crossref","first-page":"519\u201325","DOI":"10.1007\/s10147-016-1078-6","article-title":"Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy","volume":"22","author":"Kitai","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"R49-20261030","doi-asserted-by":"crossref","first-page":"2392\u201397","DOI":"10.1016\/j.ejso.2019.06.015","article-title":"Early recurrence in peritoneal metastasis of appendiceal neoplasm: survival and prognostic factors","volume":"45","author":"Kyang","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R50-20261030","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"key":"R51-20261030","first-page":"61\u201363","article-title":"Splenectomy revisited in 2011: impact on hematologic toxicities while performing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"2","author":"Deslauriers","year":"2011","journal-title":"J Gastrointest Oncol"},{"key":"R52-20261030","doi-asserted-by":"crossref","first-page":"1316\u201325","DOI":"10.1002\/jso.27842","article-title":"New insights in the management of pseudomyxoma peritonei","volume":"130","author":"Pastier","year":"2024","journal-title":"J Surg Oncol"},{"key":"R53-20261030","first-page":"3\u201315","article-title":"Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Acs","year":"2024","journal-title":"Innov Surg Sci"},{"key":"R54-20261030","first-page":"2525\u201333","article-title":"The chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"126","year":"2020","journal-title":"Cancer"},{"key":"R55-20261030","doi-asserted-by":"crossref","first-page":"1207\u201312","DOI":"10.1007\/s13304-020-00788-5","article-title":"Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study","volume":"72","author":"Di Leo","year":"2020","journal-title":"Updates Surg"},{"key":"R56-20261030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12957-021-02171-z","article-title":"Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index","volume":"19","author":"Trilling","year":"2021","journal-title":"World J Surg Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:02:34Z","timestamp":1793401354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003107","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2025-04-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}